SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway.

"Declarations Ethics approval and consent to participateAll animal experiments were approved by the Animal Welfare Ethics Committee of Zhejiang Academy of Traditional Chinese Medicine (Approval no. KTSC2020390) for the use of animals and conducted in accordance with the National Institutes of Health Laboratory Animal Care and Use Guidelines.All procedures performed in studies involving human participants were in accordance with the standards upheld by the Ethics Committee of Tongde Hospital of Zhejiang Province (Approval no. 2016003) and with those of the 1964 Helsinki Declaration and its later amendments for ethical research involving human subjects. Consent for publicationNot applicable. Competing interestsNo conflicts of interest. Competing interests No conflicts of interest."

"Funding This work was supported by the Medical Scientific Research Project of Chengdu Health Commission. (Grant No. 2020016)."